United States Hemophilia Treatment Drugs Market Report 2017

January 2017 | 115 pages | ID: UA0D2F305D2EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Hemophilia Treatment Drugs

Revenue, means the sales value of Hemophilia Treatment Drugs

This report studies sales (consumption) of Hemophilia Treatment Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Pfizer
• Biotest
• CSL Behring
• Kedrion
• Octapharma
• Shire
• Novo Nordisk
• Bayer
• F. Hoffmann-La Roche
• Biogen

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Recombinant Coagulation Factor Concentrates
• Plasma Derived Coagulation Factor Concentrates
• Desmopressin
• Antifibrinolytic Agents

Split by applications, this report focuses on sales, market share and growth rate of Hemophilia Treatment Drugs in each application, can be divided into

• Hemophilia A
• Hemophilia B
• Others

Contents

United States Hemophilia Treatment Drugs Market Report 2017

1 HEMOPHILIA TREATMENT DRUGS OVERVIEW

1.1 Product Overview and Scope of Hemophilia Treatment Drugs
1.2 Classification of Hemophilia Treatment Drugs
  1.2.1 Recombinant Coagulation Factor Concentrates
  1.2.2 Plasma Derived Coagulation Factor Concentrates
  1.2.3 Desmopressin
  1.2.4 Antifibrinolytic Agents
1.3 Application of Hemophilia Treatment Drugs
  1.3.1 Hemophilia A
  1.3.2 Hemophilia B
  1.3.3 Others
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Hemophilia Treatment Drugs (2012-2022)
  1.4.1 United States Hemophilia Treatment Drugs Sales and Growth Rate (2012-2022)
  1.4.2 United States Hemophilia Treatment Drugs Revenue and Growth Rate (2012-2022)

2 UNITED STATES HEMOPHILIA TREATMENT DRUGS COMPETITION BY MANUFACTURERS

2.1 United States Hemophilia Treatment Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Hemophilia Treatment Drugs Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Hemophilia Treatment Drugs Average Price by Manufactures (2015 and 2016)
2.4 Hemophilia Treatment Drugs Market Competitive Situation and Trends
  2.4.1 Hemophilia Treatment Drugs Market Concentration Rate
  2.4.2 Hemophilia Treatment Drugs Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES HEMOPHILIA TREATMENT DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2012-2017)

3.1 United States Hemophilia Treatment Drugs Sales and Market Share by States (2012-2017)
3.2 United States Hemophilia Treatment Drugs Revenue and Market Share by States (2012-2017)
3.3 United States Hemophilia Treatment Drugs Price by States (2012-2017)

4 UNITED STATES HEMOPHILIA TREATMENT DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2012-2017)

4.1 United States Hemophilia Treatment Drugs Sales and Market Share by Type (2012-2017)
4.2 United States Hemophilia Treatment Drugs Revenue and Market Share by Type (2012-2017)
4.3 United States Hemophilia Treatment Drugs Price by Type (2012-2017)
4.4 United States Hemophilia Treatment Drugs Sales Growth Rate by Type (2012-2017)

5 UNITED STATES HEMOPHILIA TREATMENT DRUGS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Hemophilia Treatment Drugs Sales and Market Share by Application (2012-2017)
5.2 United States Hemophilia Treatment Drugs Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES HEMOPHILIA TREATMENT DRUGS MANUFACTURERS PROFILES/ANALYSIS

6.1 Pfizer
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Hemophilia Treatment Drugs Product Type, Application and Specification
    6.1.2.1 Recombinant Coagulation Factor Concentrates
    6.1.2.2 Plasma Derived Coagulation Factor Concentrates
  6.1.3 Pfizer Hemophilia Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Biotest
  6.2.2 Hemophilia Treatment Drugs Product Type, Application and Specification
    6.2.2.1 Recombinant Coagulation Factor Concentrates
    6.2.2.2 Plasma Derived Coagulation Factor Concentrates
  6.2.3 Biotest Hemophilia Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 CSL Behring
  6.3.2 Hemophilia Treatment Drugs Product Type, Application and Specification
    6.3.2.1 Recombinant Coagulation Factor Concentrates
    6.3.2.2 Plasma Derived Coagulation Factor Concentrates
  6.3.3 CSL Behring Hemophilia Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Kedrion
  6.4.2 Hemophilia Treatment Drugs Product Type, Application and Specification
    6.4.2.1 Recombinant Coagulation Factor Concentrates
    6.4.2.2 Plasma Derived Coagulation Factor Concentrates
  6.4.3 Kedrion Hemophilia Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Octapharma
  6.5.2 Hemophilia Treatment Drugs Product Type, Application and Specification
    6.5.2.1 Recombinant Coagulation Factor Concentrates
    6.5.2.2 Plasma Derived Coagulation Factor Concentrates
  6.5.3 Octapharma Hemophilia Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Shire
  6.6.2 Hemophilia Treatment Drugs Product Type, Application and Specification
    6.6.2.1 Recombinant Coagulation Factor Concentrates
    6.6.2.2 Plasma Derived Coagulation Factor Concentrates
  6.6.3 Shire Hemophilia Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Novo Nordisk
  6.7.2 Hemophilia Treatment Drugs Product Type, Application and Specification
    6.7.2.1 Recombinant Coagulation Factor Concentrates
    6.7.2.2 Plasma Derived Coagulation Factor Concentrates
  6.7.3 Novo Nordisk Hemophilia Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Bayer
  6.8.2 Hemophilia Treatment Drugs Product Type, Application and Specification
    6.8.2.1 Recombinant Coagulation Factor Concentrates
    6.8.2.2 Plasma Derived Coagulation Factor Concentrates
  6.8.3 Bayer Hemophilia Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 F. Hoffmann-La Roche
  6.9.2 Hemophilia Treatment Drugs Product Type, Application and Specification
    6.9.2.1 Recombinant Coagulation Factor Concentrates
    6.9.2.2 Plasma Derived Coagulation Factor Concentrates
  6.9.3 F. Hoffmann-La Roche Hemophilia Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Biogen
  6.10.2 Hemophilia Treatment Drugs Product Type, Application and Specification
    6.10.2.1 Recombinant Coagulation Factor Concentrates
    6.10.2.2 Plasma Derived Coagulation Factor Concentrates
  6.10.3 Biogen Hemophilia Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview

7 HEMOPHILIA TREATMENT DRUGS MANUFACTURING COST ANALYSIS

7.1 Hemophilia Treatment Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Hemophilia Treatment Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Hemophilia Treatment Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Hemophilia Treatment Drugs Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES HEMOPHILIA TREATMENT DRUGS MARKET FORECAST (2017-2022)

11.1 United States Hemophilia Treatment Drugs Sales, Revenue Forecast (2017-2022)
11.2 United States Hemophilia Treatment Drugs Sales Forecast by Type (2017-2022)
11.3 United States Hemophilia Treatment Drugs Sales Forecast by Application (2017-2022)
11.4 Hemophilia Treatment Drugs Price Forecast (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Hemophilia Treatment Drugs
Table Classification of Hemophilia Treatment Drugs
Figure United States Sales Market Share of Hemophilia Treatment Drugs by Type in 2015
Figure Recombinant Coagulation Factor Concentrates Picture
Figure Plasma Derived Coagulation Factor Concentrates Picture
Figure Desmopressin Picture
Figure Antifibrinolytic Agents Picture
Table Application of Hemophilia Treatment Drugs
Figure United States Sales Market Share of Hemophilia Treatment Drugs by Application in 2015
Figure Hemophilia A Examples
Figure Hemophilia B Examples
Figure Others Examples
Figure United States Hemophilia Treatment Drugs Sales and Growth Rate (2012-2022)
Figure United States Hemophilia Treatment Drugs Revenue and Growth Rate (2012-2022)
Table United States Hemophilia Treatment Drugs Sales of Key Manufacturers (2015 and 2016)
Table United States Hemophilia Treatment Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Hemophilia Treatment Drugs Sales Share by Manufacturers
Figure 2016 Hemophilia Treatment Drugs Sales Share by Manufacturers
Table United States Hemophilia Treatment Drugs Revenue by Manufacturers (2015 and 2016)
Table United States Hemophilia Treatment Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Hemophilia Treatment Drugs Revenue Share by Manufacturers
Table 2016 United States Hemophilia Treatment Drugs Revenue Share by Manufacturers
Table United States Market Hemophilia Treatment Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Hemophilia Treatment Drugs Average Price of Key Manufacturers in 2015
Figure Hemophilia Treatment Drugs Market Share of Top 3 Manufacturers
Figure Hemophilia Treatment Drugs Market Share of Top 5 Manufacturers
Table United States Hemophilia Treatment Drugs Sales by States (2012-2017)
Table United States Hemophilia Treatment Drugs Sales Share by States (2012-2017)
Figure United States Hemophilia Treatment Drugs Sales Market Share by States in 2015
Table United States Hemophilia Treatment Drugs Revenue and Market Share by States (2012-2017)
Table United States Hemophilia Treatment Drugs Revenue Share by States (2012-2017)
Figure Revenue Market Share of Hemophilia Treatment Drugs by States (2012-2017)
Table United States Hemophilia Treatment Drugs Price by States (2012-2017)
Table United States Hemophilia Treatment Drugs Sales by Type (2012-2017)
Table United States Hemophilia Treatment Drugs Sales Share by Type (2012-2017)
Figure United States Hemophilia Treatment Drugs Sales Market Share by Type in 2015
Table United States Hemophilia Treatment Drugs Revenue and Market Share by Type (2012-2017)
Table United States Hemophilia Treatment Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Hemophilia Treatment Drugs by Type (2012-2017)
Table United States Hemophilia Treatment Drugs Price by Type (2012-2017)
Figure United States Hemophilia Treatment Drugs Sales Growth Rate by Type (2012-2017)
Table United States Hemophilia Treatment Drugs Sales by Application (2012-2017)
Table United States Hemophilia Treatment Drugs Sales Market Share by Application (2012-2017)
Figure United States Hemophilia Treatment Drugs Sales Market Share by Application in 2015
Table United States Hemophilia Treatment Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Hemophilia Treatment Drugs Sales Growth Rate by Application (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Hemophilia Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Hemophilia Treatment Drugs Sales Market Share (2012-2017)
Table Biotest Basic Information List
Table Biotest Hemophilia Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Biotest Hemophilia Treatment Drugs Sales Market Share (2012-2017)
Table CSL Behring Basic Information List
Table CSL Behring Hemophilia Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table CSL Behring Hemophilia Treatment Drugs Sales Market Share (2012-2017)
Table Kedrion Basic Information List
Table Kedrion Hemophilia Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Kedrion Hemophilia Treatment Drugs Sales Market Share (2012-2017)
Table Octapharma Basic Information List
Table Octapharma Hemophilia Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Octapharma Hemophilia Treatment Drugs Sales Market Share (2012-2017)
Table Shire Basic Information List
Table Shire Hemophilia Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Shire Hemophilia Treatment Drugs Sales Market Share (2012-2017)
Table Novo Nordisk Basic Information List
Table Novo Nordisk Hemophilia Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Novo Nordisk Hemophilia Treatment Drugs Sales Market Share (2012-2017)
Table Bayer Basic Information List
Table Bayer Hemophilia Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Bayer Hemophilia Treatment Drugs Sales Market Share (2012-2017)
Table F. Hoffmann-La Roche Basic Information List
Table F. Hoffmann-La Roche Hemophilia Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table F. Hoffmann-La Roche Hemophilia Treatment Drugs Sales Market Share (2012-2017)
Table Biogen Basic Information List
Table Biogen Hemophilia Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Biogen Hemophilia Treatment Drugs Sales Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Hemophilia Treatment Drugs
Figure Manufacturing Process Analysis of Hemophilia Treatment Drugs
Figure Hemophilia Treatment Drugs Industrial Chain Analysis
Table Raw Materials Sources of Hemophilia Treatment Drugs Major Manufacturers in 2015
Table Major Buyers of Hemophilia Treatment Drugs
Table Distributors/Traders List
Figure United States Hemophilia Treatment Drugs Production and Growth Rate Forecast (2017-2022)
Figure United States Hemophilia Treatment Drugs Revenue and Growth Rate Forecast (2017-2022)
Table United States Hemophilia Treatment Drugs Production Forecast by Type (2017-2022)
Table United States Hemophilia Treatment Drugs Consumption Forecast by Application (2017-2022)
Table United States Hemophilia Treatment Drugs Sales Forecast by States (2017-2022)
Table United States Hemophilia Treatment Drugs Sales Share Forecast by States (2017-2022)